Femasys Inc financial data

Symbol
FEMY on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3950 Johns Creek Court, Suite 100, Suwanee, GA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 688 % -23%
Quick Ratio 35.4 % +16.4%
Debt-to-equity 56.8 % +401%
Return On Equity -120 % -49.7%
Return On Assets -76.5 % -6.29%
Operating Margin -1.73K % -72.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.2M shares +47.5%
Common Stock, Shares, Outstanding 22.2M shares +47.5%
Entity Public Float 6.83M USD -70.5%
Common Stock, Value, Issued 22.4K USD +47.1%
Weighted Average Number of Shares Outstanding, Basic 22.2M shares +69.5%
Weighted Average Number of Shares Outstanding, Diluted 22.2M shares +69.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 950K USD -20.6%
Research and Development Expense 7.89M USD +31.9%
Selling and Marketing Expense 1.55M USD +93.9%
General and Administrative Expense 7.3M USD +33.4%
Operating Income (Loss) -16.5M USD -36.9%
Nonoperating Income (Expense) -213K USD -166%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.69M USD -62%
Income Tax Expense (Benefit) -1.75K USD
Net Income (Loss) Attributable to Parent -16.7M USD -42.5%
Earnings Per Share, Basic -0.84 USD/shares +13.4%
Earnings Per Share, Diluted -0.84 USD/shares +13.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD +26.4%
Accounts Receivable, after Allowance for Credit Loss, Current 92.5K USD -40.6%
Inventory, Net 1.32M USD +126%
Other Assets, Current 998K USD +69.7%
Assets, Current 15.9M USD +32.4%
Property, Plant and Equipment, Net 1.26M USD +0.56%
Operating Lease, Right-of-Use Asset 2.38M USD +673%
Other Assets, Noncurrent 957K USD +10.6%
Assets 20.3M USD +41.7%
Accounts Payable, Current 952K USD +74%
Employee-related Liabilities, Current 1.08M USD +1171%
Accrued Liabilities, Current 886K USD +65.1%
Liabilities, Current 2.46M USD +78.4%
Operating Lease, Liability, Noncurrent 2.04M USD +7023%
Liabilities 9.03M USD +528%
Retained Earnings (Accumulated Deficit) -117M USD -16.7%
Stockholders' Equity Attributable to Parent 11.3M USD -12.6%
Liabilities and Equity 20.3M USD +41.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.57M USD -72.5%
Net Cash Provided by (Used in) Financing Activities 778K USD
Net Cash Provided by (Used in) Investing Activities -90.2K USD -913%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.4M shares +47.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.5M USD +26.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 26M USD +15%
Deferred Tax Assets, Gross 26.6M USD +16.9%
Operating Lease, Liability 2.44M USD +532%
Depreciation 70K USD -46.8%
Payments to Acquire Property, Plant, and Equipment 64.6K USD +625%
Property, Plant and Equipment, Gross 4.94M USD +4.51%
Operating Lease, Liability, Current 407K USD +13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 629K USD +1238%
Lessee, Operating Lease, Liability, to be Paid, Year One 452K USD -19%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 655K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.7M USD +10.1%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 681K USD
Operating Lease, Payments 3.32M USD
Additional Paid in Capital 125M USD +12.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.25K USD -11.9%
Share-based Payment Arrangement, Expense 735K USD +206%
Interest Expense 525K USD +4135%